Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Usefulness of Probiotics in the Management of NAFLD: Evidence and Involved Mechanisms of Action from Preclinical and Human Models
Laura Arellano-García, María P. Portillo, J. Alfredo Martínéz, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3167-3167
Open Access | Times Cited: 22

Showing 22 citing articles:

Pediatric obesity—Long‐term consequences and effect of weight loss
Claude Marcus, Pernilla Danielsson, Emilia Hagman
Journal of Internal Medicine (2022) Vol. 292, Iss. 6, pp. 870-891
Open Access | Times Cited: 124
The Effects of Probiotics, Prebiotics and Synbiotics in Non-Alcoholic Fat Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review
Rodrigo Zamignan Carpi, Sandra Maria Barbalho, Kátia Portero Sloan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8805-8805
Open Access | Times Cited: 87
NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment Options
Natalia G. Vallianou, Dimitris Kounatidis, Sotiria Psallida, et al.
Metabolites (2024) Vol. 14, Iss. 7, pp. 366-366
Open Access | Times Cited: 18
Gut Microbiome in the Progression of NAFLD, NASH and Cirrhosis, and Its Connection with Biotics: A Bibliometric Study Using Dimensions Scientific Research Database
Salvatore Pezzino, Maria Sofia, Chiara Mazzone, et al.
Biology (2023) Vol. 12, Iss. 5, pp. 662-662
Open Access | Times Cited: 17
Beneficial Effects of Viable and Heat-Inactivated Lactobacillus rhamnosus GG Administration on Oxidative Stress and Inflammation in Diet-Induced NAFLD in Rats
Laura Arellano-García, Jenifer Trepiana, J. Alfredo Martínéz, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 717-717
Open Access | Times Cited: 16
The gut-liver axis: emerging mechanisms and therapeutic approaches for nonalcoholic fatty liver disease and type 2 diabetes mellitus
Monika Bhardwaj, Papiya Mitra Mazumder
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 5
Effects of probiotics on non-alcoholic fatty liver disease: a review of human clinical trials
Chujin Cao, Mengxia Shi, Xiuru Wang, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 15
The effect of probiotic consumption on lipid profile, glycemic index, inflammatory markers, and liver function in NAFLD patients: A systematic review and meta-analysis of randomized controlled trials
Sadegh Mozaffari, Mahdeyeh Aliari, Solaleh Emamgholipour, et al.
Journal of Diabetes and its Complications (2024) Vol. 38, Iss. 8, pp. 108780-108780
Closed Access | Times Cited: 4
Gut microbiome in non-alcoholic fatty liver disease
Anastasios Mpountouridis, Christina Tsigalou, Ioanna Bezirtzoglou, et al.
Frontiers in Gastroenterology (2025) Vol. 3
Open Access
Potential Therapeutic Strategies in the Treatment of Metabolic-Associated Fatty Liver Disease
Aleksandra Bołdys, Łukasz Bułdak, Mateusz Maligłówka, et al.
Medicina (2023) Vol. 59, Iss. 10, pp. 1789-1789
Open Access | Times Cited: 9
Updated Insights into Probiotics and Hepatobiliary Diseases
Xiaoyu Xu, Cheng Zhang, Guo‐Yi Tang, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 515-515
Open Access | Times Cited: 3
Supplementation of Lactobacillus plantarum ATCC14917 mitigates non-alcoholic fatty liver disease in high-fat-diet-fed rats
Xingjian Wen, Hejing Liu, Luo Xiao-ling, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 8
Polyphenol-Rich Liupao Tea Extract Prevents High-Fat Diet-Induced MAFLD by Modulating the Gut Microbiota
Waijiao Tang, Mengfei Yuan, Zewen Li, et al.
Nutrients (2022) Vol. 14, Iss. 22, pp. 4930-4930
Open Access | Times Cited: 10
The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study
Ki‐Kwang Oh, Sang Jun Yoon, Su-Been Lee, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 4
Prebiotics and Probiotics: Effects on Dyslipidemia and NAFLD/NASH and the Associated Mechanisms of Action
Eduardo Fernández‐Martínez, Alicia Rodríguez-Pastén, Nury Pérez‐Hernández, et al.
Current Pharmaceutical Biotechnology (2022) Vol. 24, Iss. 5, pp. 633-646
Closed Access | Times Cited: 7
A Transcriptomic Response to Lactiplantibacillus plantarum-KCC48 against High-Fat Diet-Induced Fatty Liver Diseases in Mice
Ilavenil Soundharrajan, Karnan Muthusamy, Jeong-Sung Jung, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6750-6750
Open Access | Times Cited: 3
Comparative effects of viable Lactobacillus rhamnosus GG and its heat‐inactivated paraprobiotic in the prevention of high‐fat high‐fructose diet‐induced non‐alcoholic fatty liver disease in rats
Laura Arellano-García, Iñaki Milton‐Laskibar, J. Alfredo Martínéz, et al.
BioFactors (2024)
Open Access
Deciphering the Gut–Liver Axis: A Comprehensive Scientific Review of Non-Alcoholic Fatty Liver Disease
Samradhi Singh, Mona Kriti, Roberto Catanzaro, et al.
Livers (2024) Vol. 4, Iss. 3, pp. 435-454
Open Access
Dietary supplementation of probiotic Lactobacillus modulates metabolic dysfunction‐associated steatotic liver disease and intestinal barrier integrity in obesity‐induced mice
Nageena Qayyum, Mohamedelfatieh Ismael, Han Haoyue, et al.
Journal of Food Science (2024)
Open Access
Postbiotics for the management of obesity, insulin resistance/type 2 diabetes and NAFLD. Beyond microbial viability
Laura Arellano-García, María P. Portillo, J. Alfredo Martínéz, et al.
Critical Reviews in Food Science and Nutrition (2024), pp. 1-24
Closed Access
Gut microbiota and nonalcoholic fatty liver disease
Bo‐Yeon Kim, Bu Kyung Kim
Kosin Medical Journal (2023) Vol. 38, Iss. 3, pp. 169-175
Open Access | Times Cited: 1
Longitudinal analysis of a dietary mouse model of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
Marissa Saenz, Jillian C. McDonough, Elizabeth Bloom-Saldana, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top